Real-time enrollment status for this alzheimer's disease clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT07177352 |
| Recruiting Status | Recruiting |
| Condition | Alzheimer's Disease |
| Phase | Clinical Trial |
| Target Enrollment | 13,000 participants |
| Active Locations | 53 sites in the US |
| Sponsor | Hoffmann-La Roche |
| Last Updated on CT.gov | February 9, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT07177352 is currently recruiting participants. This clinical trial study for alzheimer's disease is actively seeking new participants at 53 locations across the United States. The study is sponsored by Hoffmann-La Roche. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07177352 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 53 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07177352 was last updated 3 weeks ago (February 9, 2026). HelloStudys verifies this status automatically.